<DOC>
	<DOCNO>NCT02430116</DOCNO>
	<brief_summary>Background : The cardiomyocytes apoptosis induce ischemia-reperfusion ( I/R ) one important factor myocardial I/R injury ( MIRI ) undergo cardiac valve replacement cardiopulmonary bypass ( CVRCPB ) , Ischemic postconditioning ( I-postC ) inhibit apoptosis myocardial cell . Consequently , study investigate key gene apoptosis signal pathway myocardium patient undergoing CVRCPB . Methods : A total 36 New York Heart Association class II III patient rheumatic heart disease ( RHD ) sex , age 21-59 year , schedule first cardiac valve replacement CPB investigator ' hospital February 2014 May 2015 , randomly divide follow three group ( n=12 ) : negative control group ( NEG group ) ; I/R group ( POS group ) ; I-postC group ( Treat group ) . In Treat group , procedure involve 5 min open ascend aorta , aortic unclamping 30 , cross-clamping 30 three cycle , ascend aorta completely open . The NEG Treat group treat . Thirty-six patient assess arrhythmia recovery myocardial contractile function reperfusion electrocardiogram degree dependence vasoactive drug . The myocardial tissue right atrial appendage obtain 3 min CPB establish NEG group , 45 min open aorta POS Treat group . In three group , myocardial tissue right atrial appendage obtain preserve −80°C experiment . The right atrial appendage three patient randomly select group fix RNA later ( Qiagen , Hilden , Germany ) centrifuge tube overnight 4°C , preserve −20°C RNA extraction . Human 12×135K Gene Array profile mRNA expression undertaken human cardiac muscle cell . Differentially express mRNAs verify quantitative real-time RT-PCR subject pathway analysis . The mRNA expression AIF , APAF1 , CYCS , Bax , caspase-3 , caspase-9 , caspase-6 , caspase-7 , BCL2 , BAG1 , PI3K assess real-time RT-PCR western blot analysis . The level myocardial apoptosis induce I/R investigate TUNEL assay . The change MIRI induce myocardial apoptosis investigate pathologic examination myocardium .</brief_summary>
	<brief_title>Mitochondrial Apoptotic Pathway Induced Myocardial Ischemia-Reperfusion Injury Human</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Reperfusion Injury</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<criteria>New York Heart Association class II III age 2159 year schedule first cardiac valve replacement CPB The patient history heart operation diabetes , history liver and/or kidney dysfunction , history coronary heart disease leave ventricular ejection fraction ( LVEF ) &lt; 0.4 , receive drug pretreatment effectssuchas hormone , ATPsensitive potassium ( KATP ) channel openers，insulin，et al . within preoperative one week ,</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>